Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 9Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Juvenile 3Multiple Myeloma 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Hematologic Neoplasms 2Breast Neoplasms 2Shwachman-Diamond Syndrome 1Sarcoma, Myeloid 1Retinoblastoma 1Primary Immunodeficiency Diseases 1Neutropenia, Severe Congenital, Autosomal Recessive 3 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Medulloblastoma 1Macrophage Activation Syndrome 1Lymphoproliferative Disorders 1Lymphoma, Large B-Cell, Diffuse 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Histiocytosis, Langerhans-Cell 1Histiocytosis 1Hemoglobinopathies 1Bone Marrow Failure Disorders 1

Interventions

fludarabine 8Cyclophosphamide 7Specimen Handling 6Cytarabine 6fludarabine phosphate 5Methotrexate 5venetoclax 4merphos 4Whole-Body Irradiation 4calaspargase pegol 3Tacrolimus 3Spinal Puncture 3Mycophenolic Acid 3Melphalan 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Biopsy 3Asparaginase 3vedolizumab 2prednylidene 2pegaspargase 2deltacortene 2decitabine and cedazuridine drug combination 2blinatumomab 2Vincristine 2Thiotepa 2Stem Cell Transplantation 2Rituximab 2Prednisone 2Prednisolone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Biphenotypic, Acute × Thiotepa × Clear all
NCT05457556 2025-12-22

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Active not recruiting
435 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03399773 2025-08-26

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡